![Cortney Caudill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cortney Caudill
Geen lopende functies
Vermogen: 469 440 $ op 31-05-2026
Profiel
Cortney Caudill formerly worked at SAMSUNG BIOLOGICS Co., Ltd., as Director-Business Development Technology, Genentech, Inc., as Principal, VaxGen, Inc., as Principal, Baxalta Schweiz AG, as Head-Drug Product External Manufacturing Network from 2014 to 2016, Spyre Therapeutics, Inc., as Chief Product Officer in 2023, and Halozyme Therapeutics, Inc., as Chief Operating Officer & Senior Vice President from 2025 to 2026.
Ms. Caudill received her Masters Business Admin degree from Fordham University and undergraduate degree from The University of Texas at Austin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-03-2026 | 7.055 ( 0,01% ) | 469 440 $ | 31-05-2026 |
Eerdere bekende functies van Cortney Caudill
| Bedrijven | Functie | Einde |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Operationeel Directeur | 30-06-2026 |
| SPYRE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 06-01-2023 |
Baxalta Schweiz AG | Corporate Officer/Principal | 01-02-2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Corporate Officer/Principal | - |
Opleiding van Cortney Caudill
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
17
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAMSUNG BIOLOGICS Co., Ltd.
 SAMSUNG BIOLOGICS Co., Ltd. BiotechnologyHealth Technology Provides biologics development and manufacturing solutions | Health Technology |
Baxalta Schweiz AG |
Kies MarketScreener 
